The complement system in cancer: ambivalence between tumour destruction and promotion
Constituting a part of the innate immune system, the complement system consists of over 50 proteins either acting as part of a 3-branch activation cascade, a well-differentiated regulatory system in fluid phase or on each tissue, or as receptors translating the activation signal to multiple cellular...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2017
|
| In: |
Immunobiology
Year: 2015, Jahrgang: 222, Heft: 1, Pages: 45-54 |
| ISSN: | 1878-3279 |
| DOI: | 10.1016/j.imbio.2015.11.008 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1016/j.imbio.2015.11.008 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0171298515300929 
|
| Verfasserangaben: | Srinivas Mamidi, Simon Höne, Michael Kirschfink |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1580782256 | ||
| 003 | DE-627 | ||
| 005 | 20220815003539.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180907r20172015xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.imbio.2015.11.008 |2 doi | |
| 035 | |a (DE-627)1580782256 | ||
| 035 | |a (DE-576)510782256 | ||
| 035 | |a (DE-599)BSZ510782256 | ||
| 035 | |a (OCoLC)1341018308 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Mamidi, Srinivas |d 1979- |e VerfasserIn |0 (DE-588)140989471 |0 (DE-627)703851179 |0 (DE-576)321299485 |4 aut | |
| 245 | 1 | 4 | |a The complement system in cancer |b ambivalence between tumour destruction and promotion |c Srinivas Mamidi, Simon Höne, Michael Kirschfink |
| 264 | 1 | |c 2017 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Available online 28 November 2015 | ||
| 500 | |a Gesehen am 07.09.2018 | ||
| 520 | |a Constituting a part of the innate immune system, the complement system consists of over 50 proteins either acting as part of a 3-branch activation cascade, a well-differentiated regulatory system in fluid phase or on each tissue, or as receptors translating the activation signal to multiple cellular effector functions. Complement serves as first line of defence against infections from bacteria, viruses and parasites by orchestrating the immune response through opsonisation, recruitment of immune cells to the site of infection and direct cell lysis. Complement is generally recognised as a protective mechanism against the formation of tumours in humans, but is often limited by various resistance mechanisms interfering with its cytotoxic action, now considered as a great barrier of successful antibody-based immunotherapy. However, recent studies also indicate a pro-tumourigenic potential of complement in certain cancers and under certain conditions. In this review, we present recent findings on the possible dual role of complement in destroying cancer, especially if resistance mechanisms are blocked, but also under certain inflammatory conditions—promoting tumour development. | ||
| 534 | |c 2015 | ||
| 650 | 4 | |a C3a | |
| 650 | 4 | |a C5a | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Complement regulatory proteins | |
| 650 | 4 | |a Complement-dependent cytotoxicity | |
| 650 | 4 | |a Opsonisation | |
| 700 | 1 | |a Höne, Simon |e VerfasserIn |0 (DE-588)1140810049 |0 (DE-627)898708095 |0 (DE-576)494067411 |4 aut | |
| 700 | 1 | |a Kirschfink, Michael |e VerfasserIn |0 (DE-588)120927152 |0 (DE-627)080974457 |0 (DE-576)292452411 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Immunobiology |d München : Elsevier, 1979 |g 222(2017), 1, Seite 45-54 |h Online-Ressource |w (DE-627)335415989 |w (DE-600)2060227-3 |w (DE-576)096290919 |x 1878-3279 |7 nnas |a The complement system in cancer ambivalence between tumour destruction and promotion |
| 773 | 1 | 8 | |g volume:222 |g year:2017 |g number:1 |g pages:45-54 |g extent:10 |a The complement system in cancer ambivalence between tumour destruction and promotion |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.imbio.2015.11.008 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0171298515300929 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180907 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 120927152 |a Kirschfink, Michael |m 120927152:Kirschfink, Michael |d 910000 |d 911600 |e 910000PK120927152 |e 911600PK120927152 |k 0/910000/ |k 1/910000/911600/ |p 3 |y j | ||
| 998 | |g 1140810049 |a Höne, Simon |m 1140810049:Höne, Simon |d 910000 |d 911600 |e 910000PH1140810049 |e 911600PH1140810049 |k 0/910000/ |k 1/910000/911600/ |p 2 | ||
| 998 | |g 140989471 |a Mamidi, Srinivas |m 140989471:Mamidi, Srinivas |p 1 |x j | ||
| 999 | |a KXP-PPN1580782256 |e 3024957936 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Srinivas Mamidi, Simon Höne, Michael Kirschfink"]},"origin":[{"dateIssuedDisp":"2017","dateIssuedKey":"2017"}],"id":{"doi":["10.1016/j.imbio.2015.11.008"],"eki":["1580782256"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"title":[{"subtitle":"experimental and clinical","title":"Immunobiology","title_sort":"Immunobiology"}],"part":{"issue":"1","pages":"45-54","year":"2017","extent":"10","volume":"222","text":"222(2017), 1, Seite 45-54"},"pubHistory":["156.1979/80,4 -"],"recId":"335415989","language":["eng"],"note":["Gesehen am 12.02.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"The complement system in cancer ambivalence between tumour destruction and promotionImmunobiology","id":{"issn":["1878-3279"],"eki":["335415989"],"zdb":["2060227-3"]},"origin":[{"dateIssuedDisp":"1979-","dateIssuedKey":"1979","publisher":"Elsevier ; Urban & Fischer","publisherPlace":"München ; Jena"}],"physDesc":[{"extent":"Online-Ressource"}]}],"person":[{"display":"Mamidi, Srinivas","roleDisplay":"VerfasserIn","role":"aut","family":"Mamidi","given":"Srinivas"},{"family":"Höne","given":"Simon","display":"Höne, Simon","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Kirschfink, Michael","role":"aut","family":"Kirschfink","given":"Michael"}],"title":[{"title_sort":"complement system in cancer","title":"The complement system in cancer","subtitle":"ambivalence between tumour destruction and promotion"}],"note":["Available online 28 November 2015","Gesehen am 07.09.2018"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1580782256","language":["eng"]} | ||
| SRT | |a MAMIDISRINCOMPLEMENT2017 | ||